Early left ventricular remodeling in acute severe aortic regurgitation: Insights from an animal model

Journal of Heart Valve Disease

Volumn 17, Issue 3, 2008, Pages 300-308

  Lachance, Dominic ^a   Plante, Éric ^a   Roussel, Élise ^a   Drolet, Marie Claude ^a   Couet, Jacques ^a   Arsenault, Marie ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; CARDIOTROPHIN 1; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRONECTIN; STAT3 PROTEIN; STAT3 PROTEIN, RAT;

ACUTE DISEASE; ANIMAL; AORTA VALVE REGURGITATION; ARTICLE; BLOOD PRESSURE; DISEASE MODEL; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE REMODELING; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WISTAR RAT;

ACUTE DISEASE; ANIMALS; AORTIC VALVE INSUFFICIENCY; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FIBRONECTINS; HEART RATE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCYTES, CARDIAC; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; STAT3 TRANSCRIPTION FACTOR; VENTRICULAR REMODELING;

EID: 53449088382     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 2003;108:2432-2438 (Pubitemid 37444401)
2. Plante E, Gaudreau M, Lachance D, et al. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation. Can J Physiol Pharmacol 2004;82:191-199 (Pubitemid 38621692)
3. Plante E, Lachance D, Gaudreau M, et al. Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation 2004;110:1477-1483 (Pubitemid 39238027)
4. Wang X, Sentex E, Chapman D, et al. Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure. Am J Physiol Heart Circ Physiol 2004;287:H118-H125 (Pubitemid 38802343)
5. Sethi R, Shao Q, Ren B, et al. Changes in betaadrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of reninangiotensin system. Mol Cell Biochem 2004;263:11-20 (Pubitemid 39256141)
6. Wang X, Sentex E, Saini HK, et al. Upregulation of b-adrenergic receptors in heart failure due to volume overload. Am J Physiol Heart Circ Physiol 2005;289:H151-H159 (Pubitemid 40934093)
7. Arsenault M, Plante E, Drolet MC, et al. Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis 2002;11:128-134 (Pubitemid 36950137)
8. Plante E, Couet J, Gaudreau M, et al. Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats. J Card Fail 2003;9:128-140 (Pubitemid 36444198)
9. Imamura T, McDermott PJ, Kent RL, et al. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res 1994;75:418-425 (Pubitemid 24256402)
10. Wei CC, Lucchesi PA, Tallaj J, et al. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol 2003;285:H784-H792 (Pubitemid 36885912)
11. Wang X, Ren B, Liu S, et al. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol 2003;94:752-763 (Pubitemid 36158255)
12. Urschel CW, Covell JW, Graham TP, et al. Effects of acute valvular regurgitation on the oxygen consumption of the canine heart. Circ Res 1968;23:33-43
13. Klepzig HH, Warner KG, Siouffi SY, et al. Hemodynamic effects of nitroglycerin in an experimental model of acute aortic regurgitation. J Am Coll Cardiol 1989;13:927-935 (Pubitemid 19087917)
14. Borer JS, Truter S, Herrold EM, et al. Myocardial fibrosis in chronic aortic regurgitation: Molecular and cellular responses to volume overload. Circulation 2002;105:1837-1842 (Pubitemid 34408895)
15. Lear W, Ruzicka M, Leenen FH. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Am J Physiol 1997;273:H641-H646
16. Ishiye M, Umemura K, Uematsu T, et al. Angiotensin ATI receptor-mediated attenuation of cardiac hypertrophy due to volume overload: Involvement of endothelin. Eur J Pharmacol 1995;280:11-17
17. Yamakawa H, Imamura T, Matsuo T, et al. Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload. Am J Physiol Heart Circ Physiol 2000;279:H2939-H2946 (Pubitemid 32005884)
18. Arnal JF, Philippe M, Laboulandine I, et al. Effect of perindopril in rat cardiac volume overload. Am Heart J 1993;126:776-782 (Pubitemid 23264858)
19. Kim S, Sada T, Mizuno M, et al. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats. Hypertens Res 1997;20:133-142
20. Bauer P, Regitz-Zagrosek V, Kallisch H, et al. Myocardial angiotensin receptor type 1 gene expression in a rat model of cardiac volume overload. Basic Res Cardiol 1997;92:139-146 (Pubitemid 27282971)
21. Wei CC, Lucchesi PA, Tallaj J, et al. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol 2003;285:H784-H792 (Pubitemid 36885912)
22. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994;74:727-739 (Pubitemid 24088533)
23. Fielitz J, Hein S, Mitrovic V, et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 2001;37:1443-1449
24. Kim YJ, Jones M, Shiota T, et al. Effect of load alterations on the effective regurgitant orifice area in chronic aortic regurgitation. Heart 2002;88:397-400
25. Murakami K, Mizushige K, Noma T, et al. Effects of perindopril on left ventricular remodeling and aortic regurgitation in rats assessed by echocardiography. Angiology 2000;51:943-952
26. Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: Dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 2003;35:1385-1394 (Pubitemid 37491181)
27. Komuro I, Kudo S, Yamazaki T, et al. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. FASEB J 1996;10:631-636 (Pubitemid 26141174)
28. Zechner D, Thuerauf DJ, Hanford DS, et al. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 1997;139:115-127 (Pubitemid 27444085)
29. Clerk A, Michael A, Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G proteincoupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy? J Cell Biol 1998;142:523-535 (Pubitemid 28361557)
30. Liao P, Georgakopoulos D, Kovacs A, et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 2001;98:12283-12288 (Pubitemid 32959865)
31. Sadoshima J, Montagne O, Wang Q, et al. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 2002;110:271-279 (Pubitemid 34787364)
32. Nicol RL, Frey N, Pearson G, et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001;20:2757-2767 (Pubitemid 32938559)
33. Takahashi N, Saito Y, Kuwahara K, et al. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol 2005;38:185-192 (Pubitemid 40038665)
34. Latchman DS. Cardiotrophin-1 (CT-1): A novel hypertrophic and cardioprotective agent. Int J Exp Pathol 1999;80:189-196 (Pubitemid 29469031)
35. Talwar S, Squire IB, Davies JE, et al. The effect of valvular regurgitation on plasma Cardiotrophin-1 in patients with normal left ventricular systolic function. Eur J Heart Fail 2000;2:387-391 (Pubitemid 32003336)
36. Wollert KC, Taga T, Saito M, et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gpl30/leukemia inhibitory factor receptordependent pathways. J Biol Chem 1996;271:9535-9545
37. Dervan J, Goldberg S. Acute aortic regurgitation: Pathophysiology and management. Cardiovasc Clin 1986;16:281-288 (Pubitemid 16158972)